期刊文献+

丹酚酸A对成纤维细胞活力、增殖及胶原合成的影响 被引量:43

Effect of Salvianolic Acid-A on NIH/3T3 Fibroblast Viability, Proliferation and Collagen Synthesis
下载PDF
导出
摘要 目的:探讨丹酚酸A对成纤维细胞增殖及胶原合成的影响。方法:常规培养NIH/3T3成纤维细胞,10^(-4)~10^(-7)mol/L丹酚酸A温育亚单层细胞22h。[~3H]-TdR掺入法测定细胞增殖,[~3H]-proline掺入法测定细胞活力,[~3H]-proline掺入、胶原酶消化法测定细胞内外胶原生成率。结果:10^(-4)~10^(-6)mol/L丹酚酸A抑制细胞增殖,除10^(-4)mol/L丹酚酸A组细胞[~3H]-proline掺入量下降,有一定细胞毒性外,其余各组均有促进细胞活力的趋势,以10^(-6)mol/L组最为明显。10^(-4)~10^(-7)mol/L丹酚酸A抑制细胞内胶原合成率,以10^(-6)mol/L作用稍强,但对细胞外胶原的分泌均无明显影响。结论:丹酚酸A能抑制成纤维细胞增殖及细胞内胶原合成,体外最佳作用浓度为10^(-6)mol/L。 Aim: To study effect of Salvianolic Acid-A (SA-A) on NIH/3T3 fibroblast functions such as viability, proliferation and collagen synthesis. Methods: NIH/3T3 fibroblasts were cultured with regular method, and incubated with 10-4-10-7mol/L SA-A for 22h. The cell viability was assayed by [3H]-proline incorporation, cell proliferation by [3H] -TdR incorporation, cell collagen synthesis rate was measured with [3H] -proline incorporation collagenase digestion. Results 10-4-10-6mol/L SA-A could inhibited fibroblast except 10-4 mol/1 SA-A which decreased cell viability, and 10-6mol/L had the best effect among three groups also 10-5-10-5mol/L SA-A inhibited intracellular collagen synthesis. 10-5mol/L showed a better effect. but both 10-5-10-6mol/L SA-A had no significant influence on extracelluar collagen secretion. Conclusion : SA-A could inhibited fibroblast proliferation and intracellular collagen synthesis, the best drug concentration perhaps was 10-6mol/L in vitro.
出处 《中西医结合肝病杂志》 CAS 2000年第1期24-25,共2页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金 上海市高等学校科学技术发展基金(96GJ04)
关键词 丹酚酸A 成纤维细胞 细胞活力 细胞增殖 药理 Salvianolic Acid-A NIH/3T3 Fibroblast Viability Proliferation Collagen Synthesis
  • 相关文献

参考文献14

二级参考文献122

  • 1田鑫,贾立群.抗癌消水膏对恶性胸腔积液模型大鼠胸膜粘连的影响[J].北京中医,2007,26(2):116-118. 被引量:6
  • 2任曲,宋颖,杨航燕,孙晓丽.CA-125检测在肺部疾病中的临床应用[J].空军总医院学报,2007,23(1):13-15. 被引量:2
  • 3姚敏 展玉涛.CAl25与结核性腹膜炎.中华实用医药杂志,2005,5(8):989-989.
  • 4Yeh HH, Chang WT, Lu KC, et al. Upregnlation of tissue factor by acti- vated Stat3 contributes to malignant pleural effusion generation via enhan- cing tumor metastasis and vascular permeability in lung adenocarcinoma[J]. PLoS One, 2013,8 (9) : e75287.
  • 5McGrath EE,Anderson PB. Diagnosis of pleural effusion:a systematic ap- proach[J]. Am J Crit Care, 2011,20 (2) : 119-127.
  • 6Thomas R, Francis R, Davies HE,et al. Interventional therapies for ma- lignant pleural effusions :the present and the future[J]. Respirology ,2014, 19(6) : 809-822.
  • 7Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion :British Thoracic Society pleural disease guideline [J]. Thorax, 2010,65 (2) : 32-40.
  • 8Ismail-Khan R, Robinson LA,Williams CC,et al. Malignant pleural meso- thelioma:a comprehensive review[J]. Caneer control,2006,13 (4) :255.
  • 9Maskell NA. Treatment options for malignant pleural effusions:patient prefereneedoes matter[J]. JAMA, 2012,307 (22) : 2432-2433.
  • 10Linares PM, Chaparro M, Gisbert JP. Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A re- view[J]. J Crohns Colitis ,2014,8(3) : 183-190.

共引文献105

同被引文献454

引证文献43

二级引证文献312

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部